We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Multifunctional Dietary Approach to Reduce Intestinal Inflammation in Cardiometabolic Risk Subjects: Insights from the SINFONI Project

MedXY Editorial Team•Oct 2, 2025•Cardiology
cardiometabolic riskgut microbiotaintestinal inflammation

The increasing prevalence of cardiometabolic (CM) diseases, which include conditions such as obesity, diabetes, and cardiovascular disease, raises significant public health concerns. These diseases are often associated with chronic low-grade inflammation, a process that can be influenced by various factors, most notably alterations in gut microbiota (GM) and compromised intestinal barrier integrity. The SINFONI project emerged to investigate a multifunctional (MF) nutritional strategy aimed at modulating inflammation and GM composition through the inclusion of diverse bioactive compounds in the diet.

Study Overview

In this randomized crossover-controlled study, 30 individuals identified as being at risk for cardiometabolic diseases participated in a dietary intervention over a period of 2 months. Participants consumed MF cereal products enriched with key bioactive components such as polyphenols, fibers, slowly digestible starch, and omega-3 fatty acids. In contrast, a control group consumed cereal products without any bioactive compounds.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension ManagementRecent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.Sep 17, 2026Genetic Influences on Macronutrient Preferences and Their Impact on Childhood Food Intake and Metabolic HealthThis cohort study links polygenic scores for macronutrient intake with specific food choices in children and adolescents, highlighting genetic pathways involving hypothalamic appetite regulation but limited effects on cardiometabolic outcomSep 12, 2026Genetic Insights into Childhood Blood Pressure and Heart Rate: Implications for Adult Cardiometabolic HealthLarge-scale GWAS highlight novel genetic loci influencing childhood blood pressure and heart rate, with polygenic risk scores predicting adult cardiometabolic outcomes, underscoring the importance of early-life genetic determinants in cardiSep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Gut Microbiota and Metabolomic Signatures as Predictors of Immunotherapy Outcomes in MASLD and Viral HCC
Distinct gut microbial profiles but shared metabolomic markers, especially fecal acetate, predict response and survival with combination immunotherapy in metabolic dysfunction-associated and viral hepatitis-related hepatocellular carcinoma.
Aug 22, 2026
Gut Microbiota-Derived Imidazole Propionate as a Predictor of Cardiometabolic Risk in Coronary Artery Disease: Evidence and Clinical ImplicationsEmerging evidence identifies circulating imidazole propionate, a gut microbiota-derived metabolite, as an independent predictor of major adverse cardiovascular events in patients with coronary artery disease, offering novel insights into peAug 18, 2026
Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis MechanismThis study reveals that bisphenol F exposure aggravates cardiomyopathy under hemodynamic stress through gut microbiota metabolism, highlighting a novel gut-heart axis involving N-acetylputrescine and potential therapeutic targets.Jul 14, 2026